Matricaria Recutita, Ext.
CAS 84082-60-0
Matricaria Recutita, Ext. (CAS 84082-60-0) is a pharmaceutical compound with 0 bioactivity targets and 58 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
MATRICARIA RECUTITA, EXT. is linked to DTXSID701042272 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Matricaria Recutita, Ext. used for in pharmaceutical contexts?
Matricaria Recutita, Ext. (CAS 84082-60-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Matricaria Recutita, Ext.?
Matricaria Recutita, Ext. has 58 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Aspartate aminotransferase increased, Back pain, Burning sensation, Craniofacial fracture, Deafness. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Matricaria Recutita, Ext. also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Chamomile Extract (Matricaria Chamomilla Extract) with EU status "permitted".
What clinical phase is Matricaria Recutita, Ext. in?
No phase 1-4 clinical development badge is rendered for Matricaria Recutita, Ext. because the matched compound identifier rows do not contain a max-phase value.